70 related articles for article (PubMed ID: 20659112)
1. Immunosuppressive activity of buxidin and E-buxenone from Buxus hyrcana.
Mesaik MA; Halim SA; Ul-Haq Z; Choudhary MI; Shahnaz S; Ayatollahi SA; Murad S; Ahmad A
Chem Biol Drug Des; 2010 Mar; 75(3):310-7. PubMed ID: 20659112
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, biological evaluation, and molecular docking studies of benzyl, alkyl and glycosyl [2-(arylamino)-4,4-dimethyl-6-oxo-cyclohex-1-ene]carbodithioates, as potential immunomodulatory and immunosuppressive agents.
El Ashry el SH; Amer MR; Abdalla OM; Aly AA; Soomro S; Jabeen A; Halim SA; Ahmed Mesaik M; Ul-Haq Z
Bioorg Med Chem; 2012 May; 20(9):3000-8. PubMed ID: 22480848
[TBL] [Abstract][Full Text] [Related]
3. New cholinesterase-inhibiting triterpenoid alkaloids from Buxus hyrcana.
Choudhary MI; Shahnaz S; Parveen S; Khalid A; Mesaik MA; Ayatollahi SA;
Chem Biodivers; 2006 Sep; 3(9):1039-52. PubMed ID: 17193337
[TBL] [Abstract][Full Text] [Related]
4. New bioactive steroidal alkaloids from Buxus hyrcana.
Babar ZU; Ata A; Meshkatalsadat MH
Steroids; 2006 Dec; 71(13-14):1045-51. PubMed ID: 17049575
[TBL] [Abstract][Full Text] [Related]
5. Chemical constituents of plants from the genus Buxus.
Zhang J; Qin XY; Zhang SD; Xu XS; Pei JP; Fu JJ
Chem Biodivers; 2015 Sep; 12(9):1289-306. PubMed ID: 26363874
[No Abstract] [Full Text] [Related]
6. Triterpenoidal alkaloids from Buxus hyrcana and their enzyme inhibitory, anti-fungal and anti-leishmanial activities.
Ata A; Iverson CD; Kalhari KS; Akhter S; Betteridge J; Meshkatalsadat MH; Orhan I; Sener B
Phytochemistry; 2010 Oct; 71(14-15):1780-6. PubMed ID: 20655557
[TBL] [Abstract][Full Text] [Related]
7. Biological and molecular docking studies on coagulin-H: Human IL-2 novel natural inhibitor.
Mesaik MA; Zaheer-Ul-Haq ; Murad S; Ismail Z; Abdullah NR; Gill HK; Atta-Ur-Rahman ; Yousaf M; Siddiqui RA; Ahmad A; Choudhary MI
Mol Immunol; 2006 Apr; 43(11):1855-63. PubMed ID: 16375970
[TBL] [Abstract][Full Text] [Related]
8. Immunosuppressive properties of flavonoids isolated from Boerhaavia diffusa Linn.
Pandey R; Maurya R; Singh G; Sathiamoorthy B; Naik S
Int Immunopharmacol; 2005 Mar; 5(3):541-53. PubMed ID: 15683850
[TBL] [Abstract][Full Text] [Related]
9. Tepoxalin, a novel immunosuppressive agent with a different mechanism of action from cyclosporin A.
Zhou L; Ritchie D; Wang EY; Barbone AG; Argentieri D; Lau CY
J Immunol; 1994 Dec; 153(11):5026-37. PubMed ID: 7963563
[TBL] [Abstract][Full Text] [Related]
10. New triterpenoid alkaloid cholinesterase inhibitors from Buxus hyrcana.
Choudhary MI; Shahnaz S; Parveen S; Khalid A; Majeed Ayatollahi SA; Atta-Ur-Rahman ; Parvez M
J Nat Prod; 2003 Jun; 66(6):739-42. PubMed ID: 12828454
[TBL] [Abstract][Full Text] [Related]
11. Non-genomic immunosuppressive actions of progesterone inhibits PHA-induced alkalinization and activation in T cells.
Chien EJ; Chang CP; Lee WF; Su TH; Wu CH
J Cell Biochem; 2006 Sep; 99(1):292-304. PubMed ID: 16619256
[TBL] [Abstract][Full Text] [Related]
12. Statins induce immunosuppressive effect on heterotopic limb allografts in rat through inhibiting T cell activation and proliferation.
Nie C; Yang D; Liu G; Dong D; Ma Z; Fu H; Zhao Z; Sun Z
Eur J Pharmacol; 2009 Jan; 602(1):168-75. PubMed ID: 19041862
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppressive activity of the immunophilin-binding drug Sanglifehrin A in human whole blood: potent inhibition of interleukin-6 produced by lymphocytes and monocytes.
Härtel C; Iblher P; Puzik A; Wortmeier K; Ebel B; Schultz C; Müller-Steinhardt M
Scand J Immunol; 2006 Jan; 63(1):26-34. PubMed ID: 16398698
[TBL] [Abstract][Full Text] [Related]
14. Curcumin inhibits mitogen stimulated lymphocyte proliferation, NFkappaB activation, and IL-2 signaling.
Ranjan D; Chen C; Johnston TD; Jeon H; Nagabhushan M
J Surg Res; 2004 Oct; 121(2):171-7. PubMed ID: 15501456
[TBL] [Abstract][Full Text] [Related]
15. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin E2 acts at two distinct pathways of T lymphocyte activation: inhibition of interleukin 2 production and down-regulation of transferrin receptor expression.
Chouaib S; Welte K; Mertelsmann R; Dupont B
J Immunol; 1985 Aug; 135(2):1172-9. PubMed ID: 2989362
[TBL] [Abstract][Full Text] [Related]
17. In silico and in vitro immunomodulatory studies on compounds of Lindelofia stylosa.
Mesaik MA; Jabeen A; Halim SA; Begum A; Khalid AS; Asif M; Fatima B; Ul-Haq Z; Choudhary MI
Chem Biol Drug Des; 2012 Mar; 79(3):290-9. PubMed ID: 22181857
[TBL] [Abstract][Full Text] [Related]
18. Suppressive effect of a novel water-soluble artemisinin derivative SM905 on T cell activation and proliferation in vitro and in vivo.
Wang JX; Tang W; Yang ZS; Wan J; Shi LP; Zhang Y; Zhou R; Ni J; Hou LF; Zhou Y; He PL; Yang YF; Li Y; Zuo JP
Eur J Pharmacol; 2007 Jun; 564(1-3):211-8. PubMed ID: 17349993
[TBL] [Abstract][Full Text] [Related]
19. FR252921, a novel immunosuppressive agent isolated from Pseudomonas fluorescens no. 408813 II. In vitro property and mode of action.
Fujine K; Abe F; Seki N; Ueda H; Hino M; Fujii T
J Antibiot (Tokyo); 2003 Feb; 56(2):62-7. PubMed ID: 12715862
[TBL] [Abstract][Full Text] [Related]
20. Additive immunosuppressive effects of 1,25-dihydroxyvitamin D3 and corticosteroids on TH1, but not TH2, responses.
Jirapongsananuruk O; Melamed I; Leung DY
J Allergy Clin Immunol; 2000 Nov; 106(5):981-5. PubMed ID: 11080724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
